Quarterly ResultMay 7, 2026, 04:06 PM
Omada Health Q1 Revenue +42% to $78M; Members Top 1M; Positive EBITDA
AI Summary
Omada Health reported strong first-quarter 2026 financial results, with revenue increasing 42% year over year to $78 million and total members surpassing one million, up 51% year over year. The company achieved positive Adjusted EBITDA of $1 million, a significant improvement from a $4 million loss in the prior year. Omada also expanded its channel partnerships to include all three leading PBMs, notably joining Optum Rx’s Weight Engage portfolio and Eli Lilly’s Employer Connect program, and raised its full-year 2026 revenue and Adjusted EBITDA guidance.
Key Highlights
- Q1 2026 Revenue: $78 million, up 42% year over year.
- Total Members: 1.02 million at Q1 end, a 51% increase year over year.
- Net Loss: Reduced to $3 million in Q1 2026 from $9 million in Q1 2025.
- Adjusted EBITDA: Turned positive at $1 million in Q1 2026 from a $4 million loss.
- Gross Margin: Increased to 62% in Q1 2026 from 58% in Q1 2025.
- Full-year 2026 Revenue Guidance: Raised to $322 million to $330 million.
- Full-year 2026 Adjusted EBITDA Guidance: Raised to $14 million to $20 million.
- Cash and cash equivalents: $212 million as of March 31, 2026.